Veradigm Stock Fundamentals

MDRXDelisted Stock  USD 13.33  0.02  0.15%   
Veradigm fundamentals help investors to digest information that contributes to Veradigm's financial success or failures. It also enables traders to predict the movement of Veradigm Stock. The fundamental analysis module provides a way to measure Veradigm's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Veradigm stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Veradigm Company Return On Asset Analysis

Veradigm's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Return On Asset

 = 

Net Income

Total Assets

More About Return On Asset | All Equity Analysis

Current Veradigm Return On Asset

    
  0.0216  
Most of Veradigm's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Veradigm is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Competition

Based on the latest financial disclosure, Veradigm has a Return On Asset of 0.0216. This is 100.25% lower than that of the Health Care Technology sector and significantly higher than that of the Health Care industry. The return on asset for all United States stocks is 115.43% lower than that of the firm.

Veradigm Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Veradigm's current stock value. Our valuation model uses many indicators to compare Veradigm value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Veradigm competition to find correlations between indicators driving Veradigm's intrinsic value. More Info.
Veradigm is regarded second in return on equity category among its peers. It is regarded fifth in return on asset category among its peers reporting about  0.24  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Veradigm is roughly  4.13 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Veradigm's earnings, one of the primary drivers of an investment's value.

Veradigm Return On Asset Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Veradigm's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Veradigm could also be used in its relative valuation, which is a method of valuing Veradigm by comparing valuation metrics of similar companies.
Veradigm is currently under evaluation in return on asset category among its peers.

Veradigm Fundamentals

About Veradigm Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Veradigm's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Veradigm using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Veradigm based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Allscripts Healthcare Solutions, Inc., together with its subsidiaries, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. Allscripts Healthcare Solutions, Inc. was founded in 1986 and is headquartered in Chicago, Illinois. Allscripts Hlthcare operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 8000 people.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Consideration for investing in Veradigm Stock

If you are still planning to invest in Veradigm check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Veradigm's history and understand the potential risks before investing.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data